News on noninvasive prenatal testing, carrier screening, and preimplantation genetic screening.
The increase in total revenues was driven primarily by sales of Natera's Panorama and Horizon reproductive health tests.
A high genetic risk score was associated with increased risk of developing type 2 diabetes in both a US and a Danish cohort of women with gestational diabetes.
The technology uses single-cell droplet digital PCR to analyze maternal blood cell populations that have been enriched for fetal cells by MACS.
The company attributed its revenue shortfall to billing issues in the prenatal testing business and announced that CFO Bryan Riggsbee will be interim CEO.
The consortium will help professional organizations develop practice guidelines and facilitate discussion on the appropriate use of reproductive genetic testing.
